share_log

Aerpio Pharmaceuticals Up 25%

Dow Jones Newswires ·  2021/08/17 13:02

DJ Aerpio Pharmaceuticals Up 25%

By Josh Beckerman

Shares of Aerpio Pharmaceuticals Inc., which is working on drugs for ocular disease and vascular stabilization, were recently up 25% to $2.57.

The company didn't appear to issue any press releases or securities filings Tuesday.

Aerpio said in May that it agreed to merge with Aadi Bioscience Inc.

Write to Josh Beckerman at josh.beckerman@wsj.com

(END) Dow Jones Newswires

August 17, 2021 13:02 ET (17:02 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする